Effect Of Rilapladib (SB-659032) On Platelet Aggregation

2014-08-27 03:42:06 | BioPortfolio


The purpose of this study is to compare the effects of repeat doses of SB-659032 with placebo on platelet aggregation in subjects.

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Diagnostic


Healthy Subjects


Rilapladib (SB-659032)


GSK Investigational Site
New South Wales





Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:42:06-0400

Clinical Trials [67 Associated Clinical Trials listed on BioPortfolio]

An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

A study in patients with atherosclerosis to assess safety, effect and PK of rilapladib vs. placebo over 12 weeks of dosing.

Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

Rilapladib is a potent and selective inhibitor of lipoprotein associated phospholipase A2 (Lp-PLA2), which was previously under development for the treatment of atherosclerosis and is curr...

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

Clinical study in healthy adult subjects to compare the adult tablet of selexipag with the tablet developed for children.

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers

This trial is conducted in China. The aim of this trial is to assess the safety and tolerability of HS-20004 in healthy Chinese subjects.

Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects

This study is a phase I, randomized, placebo-controlled, double-blind (sponsor unblind), three part study. The primary objective of the study is to characterize the safety, and tolerabilit...

PubMed Articles [7772 Associated PubMed Articles listed on BioPortfolio]

Age-related changes in intra-ventricular kinetic energy: a physiological or pathological adaptation?

Ageing has important deleterious effects on the cardiovascular system. We sought to compare intra-ventricular kinetic energy (KE) in healthy subjects of varying ages to subjects with ventricular dysfu...

Slow wave oscillations in awake healthy subjects - methodological and physiological considerations.

Detection of pathological slow wave oscillations (0.5-7 Hz) in awake subjects have gained increasing interest in clinical diagnostics. Their significance, however, is hampered by the occasional presen...

Patients With Coeliac Disease Reported Highter Consumption of Added Sugar and Total Fat Than Healthy Individuals.

To compare the dietary pattern between subjects with coeliac disease (CD) (cases) and subjects without (healthy controls).

Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.

The International Conference on Harmonisation E14 guideline mandates an intensive cardiac safety evaluation in a clinical thorough QT study, typically in healthy subjects, for all new non-antiarrhythm...

Motor unit number index (MUNIX) in the nasalis muscle in healthy subjects and patients with amyotrophic lateral sclerosis.

Motor unit number Index (MUNIX) is a quick and feasible electrophysiological technique which estimates the number of motor neurons in limb muscles in healthy and ALS subjects. This study explores the ...

Medical and Biotech [MESH] Definitions

Books intended for use in the study of specific subjects, containing systematic presentation of the principles and essential knowledge of the subjects.

A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects (e.g., age-matched controls).

Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.

Persons who are enrolled in research studies or who are otherwise the subjects of research.

Hospital or other institutional committees established to protect the welfare of research subjects. Federal regulations (the "Common Rule" (45 CFR 46)) mandate the use of these committees to monitor federally-funded biomedical and behavioral research involving human subjects.

More From BioPortfolio on "Effect Of Rilapladib (SB-659032) On Platelet Aggregation"

Quick Search

Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Searches Linking to this Trial